Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients

Polymorphisms in Catechol- O -Methyltransferase Modify Treatment Effects of Aspirin on Risk of Cardiovascular Disease

(2014) Kathryn T. Hall et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Catechol-O-Methyltransferase Val158Met Polymorphism Is Associated with Somatosensory Amplification and Nocebo Responses

(2014) Laura Wendt et al.   PLoS One

Affective temperaments and ego defense mechanisms associated with somatic symptom severity in a large sample

(2013) Thomas N. Hyphantis et al.   JOURNAL OF AFFECTIVE DISORDERS

To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent

(2012) Rebecca Erwin Wells et al.   AMERICAN JOURNAL OF BIOETHICS

Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome

(2012) Kathryn T. Hall et al.   PLoS One

Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches

(2011) Dimos D Mitsikostas et al.   CEPHALALGIA

Association study on catechol-O-methyltransferase (COMT) Val158Met gene polymorphism and NEO-FFI

(2010) Jun Aoki et al.   PSYCHIATRY RESEARCH

Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

(2009) Santiago Rodriguez et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A systematic review of adverse events in placebo groups of anti-migraine clinical trials

(2009) Martina Amanzio et al.   PAIN

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

(2008) Keizo Kanasaki et al.   NATURE

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

(2008) Ted J Kaptchuk et al.   BMJ-British Medical Journal